Ex Parte SHOEMAKER - Page 5




          Appeal No. 2003-2062                                                        
          Application 09/853,568                                                      


               iconic labels 30 need not be pictorial, but rather may be              
               colored or other symbols such as a blue circle or a red                
               square.  While these colored symbols may not immediately be            
               associated with a particular medicine or use, the patient              
               will associate the colored symbols with certain medicine or            
               uses much more quickly than a purely textual label.                    

               With respect to dependent claims 2 and 18 on appeal, it is             
          clear from Mayfield (Figs. 4-5) that the markers/labels (22) are            
          disposed on an external surface of the medicine                             
          receptacle/housing, and that the marker/label (22) is an icon               
          which contains no alphanumeric characters.                                  


               Appellant’s arguments in the brief (pages 6-8) do nothing to           
          alter our view of Mayfield as expressed above.  Once educated by            
          repeated use of the same icon for the exact same medication for a           
          sufficient period of time (weeks, months or years), we are                  
          convinced that most users would come to recognize that icon as              
          identifying or describing a particular medication and its uses,             
          etc., without reference to another source.  Likewise, after such            
          repeated use, the icon itself becomes descriptive of the                    
          medication because of the mental association a long term user               
          makes regarding the particular medication that icon represents.             




                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007